- Myoglobin, a heme-containing protein used as a clinical biomarker and in food testing, is gaining traction in diagnostic, research, and food quality applications due to its sensitivity in detecting early myocardial infarction and its role in muscle oxygen transport analysis
- The growing demand for myoglobin is primarily fueled by the increasing prevalence of cardiovascular diseases, a rising focus on rapid and point-of-care diagnostics, and expanding research in muscle physiology and meat quality evaluation
- North America dominated the myoglobin market with the largest revenue share of 42.1% in 2024, driven by advanced healthcare infrastructure, high cardiovascular disease burden, and strong R&D investments across diagnostic and pharmaceutical sectors, especially in the U.S., where rapid assay adoption and public-private collaborations are prominent
- Asia-Pacific is expected to be the fastest growing region in the myoglobin market during the forecast period due to improving diagnostic capabilities, growing healthcare awareness, and increased government investment in medical research
- The human myoglobin segment dominated the market with a market share of 54.8% in 2024, attributed to its critical clinical role in cardiac diagnostics and widespread use in hospitals, diagnostic labs, and emergency care settings
